These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16603964)

  • 1. Effect of nos inhibition on retinal arterial and capillary circulation in early arterial hypertension.
    Michelson G; Wärntges S; Harazny J; Oehmer S; Delles C; Schmieder RE
    Retina; 2006 Apr; 26(4):437-44. PubMed ID: 16603964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of blood flow on arteriolar wall-to-lumen ratio in the human retinal circulation in vivo.
    Ritt M; Harazny JM; Ott C; Raff U; Lehmann M; Michelson G; Schmieder RE
    Microvasc Res; 2012 Mar; 83(2):111-7. PubMed ID: 22036673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired endothelial function of the retinal vasculature in hypertensive patients.
    Delles C; Michelson G; Harazny J; Oehmer S; Hilgers KF; Schmieder RE
    Stroke; 2004 Jun; 35(6):1289-93. PubMed ID: 15073389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valsartan and retinal endothelial function in elderly hypertensive patients.
    Oehmer S; Harazny J; Delles C; Schwarz T; Handrock R; Michelson G; Schmieder RE
    Blood Press; 2006; 15(3):185-91. PubMed ID: 16864162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of nitric oxide to the blood pressure and arterial responses to exercise in humans.
    Campbell R; Fisher JP; Sharman JE; McDonnell BJ; Frenneaux MP
    J Hum Hypertens; 2011 Apr; 25(4):262-70. PubMed ID: 20505750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of NO synthase inhibition on retinal vessel reaction to isometric exercise in healthy humans.
    Lasta M; Polak K; Luksch A; Garhofer G; Schmetterer L
    Acta Ophthalmol; 2012 Jun; 90(4):362-8. PubMed ID: 20636485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired increase of retinal capillary blood flow to flicker light exposure in arterial hypertension.
    Ritt M; Harazny JM; Ott C; Raff U; Bauernschubert P; Lehmann M; Michelson G; Schmieder RE
    Hypertension; 2012 Sep; 60(3):871-6. PubMed ID: 22777934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome.
    Brillante DG; O'Sullivan AJ; Brillante RE; Howes LG
    Blood Press; 2009; 18(3):142-8. PubMed ID: 19462315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AT1 receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans.
    Bellien J; Iacob M; Eltchaninoff H; Bourkaib R; Thuillez C; Joannides R
    Clin Sci (Lond); 2007 Jun; 112(7):393-401. PubMed ID: 17125466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of l-arginine transport in platelets by asymmetric dimethylarginine and N-monomethyl-l-arginine: effects of arterial hypertension.
    Brunini T; Moss M; Siqueira M; Meirelles L; Rozentul A; Mann G; Ellory J; Soares de Moura R; Mendes-Ribeiro A
    Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):738-40. PubMed ID: 15554917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
    Tilton RG; Chang KC; LeJeune WS; Stephan CC; Brock TA; Williamson JR
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of NO in the control of choroidal blood flow during a decrease in ocular perfusion pressure.
    Simader C; Lung S; Weigert G; Kolodjaschna J; Fuchsjäger-Mayrl G; Schmetterer L; Polska E
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):372-7. PubMed ID: 19124845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men.
    Tran D; Lowy A; Howes JB; Howes LG
    Diabetes Obes Metab; 2005 May; 7(3):273-81. PubMed ID: 15811145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo quantification of endotoxin-induced nitric oxide production in pigs from Na15NO3-infusion.
    Santak B; Radermacher P; Iber T; Adler J; Wachter U; Vassilev D; Georgieff M; Vogt J
    Br J Pharmacol; 1997 Dec; 122(8):1605-10. PubMed ID: 9422804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose-response study of nitric oxide synthase inhibition in different vascular beds in man.
    Hjorth Lassen L; Klingenberg Iversen H; Olesen J
    Eur J Clin Pharmacol; 2003 Oct; 59(7):499-505. PubMed ID: 13680036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholine acutely modifies nitric oxide synthase function in the human coronary circulation.
    Miner SE; Al-Hesayen A; Nield LE; Gori T; Parker JD
    Exp Physiol; 2010 Dec; 95(12):1167-76. PubMed ID: 20817701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats.
    Maeda T; Yoshimura T; Ohshige A; Koyama H; Ito M; Okamura H
    Artery; 1998; 23(1):1-9. PubMed ID: 10846613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
    Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
    Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparate systemic and renal blocking properties of angiotensin II antagonists during exogenous angiotensin II administration: implications for treatment.
    Willemsen JM; Rabelink TJ; Boer P; Gaillard CA
    J Hum Hypertens; 2004 Dec; 18(12):857-63. PubMed ID: 15361886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition.
    Millar CG; Thiemermann C
    Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.